Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...

During surgery, a blood clot can kill in minutes. That's why heparin sulfate, a powerful blood thinner, is one of the most ...

A new study published in Therapeutic Innovation & Regulatory Science provides crucial insights into the design and ...

Speeding up drug discovery in the age of AI may come down to a concept that's comfortingly old-fashioned: Consulting a ...

Real-time ¹⁹F NMR enables faster, more efficient pharmaceutical synthesis by improving reaction monitoring, scalability, and ...

The International Society for Stem Cell Research (ISSCR) has released "Charting the Translational Pathway: ISSCR Best ...

Macrolides are an important class of antibiotics that includes drugs such as azithromycin and erythromycin, which are widely ...

Research shows pharmaceutical manufacturers face a growing market and will need OEMs and suppliers to overcome operational ...

The company applies AI to optimize molecules across discovery and production with aims to contribute to the rebuilding of U.S.-based drug innovation and manufacturing.

Manufacturing differences between ranibizumab and aflibercept biosimilars might shape pricing, uptake, and patient access globally.